Dr RR Baliga's "Got Knowledge Doc" Podkast

A fascinating step forward in Nature —where immunology meets cardiology. 🧬❤️   This study shows that engineered dendritic cells can locally reprogram the immune response , reduce fibrosis, and improve cardiac function—without systemic immunosuppression.   The insight is simple, yet profound: 👉 Heart failure is not just hemodynamic—it is immunologic.   From FAP-targeted delivery to checkpoint-med...

🧠⏳ Age. Biology. Truth.   A compelling Perspective in the New England Journal of Medicine challenges one of medicine's quiet assumptions: that age equals risk.   Two patients may share a birth year—but not a biology. From epigenetic clocks to physiological reserve, the evidence is clear: chronologic age is an imperfect proxy for clinical decision-making     ⚠️ The consequence? Missed prevention...

Why do GLP-1 therapies transform some patients—and barely move the needle in others? 🧬💉   A recent Nature study (~28,000 participants) identifies GLP1R and GIPR variants linked to both weight loss efficacy and GI side effects.   📊 Signal: modest for weight loss, stronger for tolerability 🧠 Insight: genetics + clinical factors explain ~25% variability 🚀 Implication: early steps toward precisio...

Master athletes challenge one of medicine's most elegant assumptions: that fitness always protects.   In the Journal of the American College of Cardiology (JACC) consensus statement on athletes with abnormal cardiovascular findings, a paradox emerges—higher fitness, yet distinct patterns of risk: atrial fibrillation, coronary calcium, myocardial fibrosis.   The lesson is not to discourage exercise...

A compelling study in PLOS Medicine : sustained moderate-to-vigorous physical activity across midlife is associated with a ~50% reduction in all-cause mortality in women (target trial emulation). Not intensity, not intermittence— consistency is the signal . For clinicians, the prescription is enduring: move often, move steadily, move for life. 🏃‍♀️💓   #PLOSMedicine #PreventiveCardiology #Lifesty...

The origins of medicine are not merely scientific—they are deeply philosophical. In our Great Doctors Series , we begin with Dhanvantari, the divine physician of Ayurveda, emerging from myth into method. From the Ocean of Milk to the clinics of today, this episode explores how healing began as a sacred science. For students and physicians alike, it is a reminder that medicine is not just practiced...

A fascinating and somewhat unsettling observation from JACC: Asia : nearly 1 in 4 STEMI patients in New Delhi had no traditional risk factors —no hypertension, diabetes, dyslipidemia, or smoking. Yet outcomes tell a different story. Despite fewer signs of heart failure at presentation, these patients had worse left ventricular dysfunction and identical in-hospital and 1-year mortality compared wit...

A thoughtful and important JACC State-of-the-Art Review reframes cardiogenic shock not as a single ICU event, but as a longitudinal survivorship journey. The article highlights recovery, remission, native heart survival, PICS, HF GDMT optimization, and the need for structured multidisciplinary postshock clinics focused on function, cognition, quality of life, and recurrent risk after discharge. A...

A landmark 10-year follow-up of the HOST-EXAM trial published in The Lancet challenges a century-old assumption: aspirin may no longer be the default for lifelong secondary prevention after PCI.   Clopidogrel demonstrated a sustained reduction in ischemic and bleeding events (HR 0.86, p=0.005), with benefits that accumulated over time—yet without a mortality difference.   The implication is subtle...

🫀 In the New England Journal of Medicine, the SMART-DECISION trial asks a practical modern question: after myocardial infarction, should stable patients without heart failure or marked left ventricular systolic dysfunction remain on beta-blockers indefinitely? In this randomized noninferiority trial, stopping beta-blockers after at least 1 year was noninferior to continuing them for the composite...

The New England Journal of Medicine has now given us randomized trial evidence for a question long guided more by extrapolation than by direct proof: in patients with established atherosclerotic cardiovascular disease, targeting LDL cholesterol to

New in Circulation : the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Ca...

📚 From prisons to clinics to classrooms — what really shapes us?   I've been exploring the philosophical work of Michel Foucault, and one idea keeps echoing:   👉 Power isn't just something imposed from above — it quietly operates through systems, language, and everyday norms.   From how we define "normal" to how institutions like schools, hospitals, and prisons function, Foucault challenges us t...

Left atrial appendage closure—promise meets proof, and proof meets pause.   In The New England Journal of Medicine , two pivotal trials draw a nuanced arc: CHAMPION-AF shows noninferior stroke prevention with less bleeding vs direct oral anticoagulants, while CLOSURE-AF tempers enthusiasm—failing noninferiority in older, high-risk patients with meaningful procedural risk.   The message is elegant...

Evolocumab steps into primary prevention—quietly, convincingly. In JAMA , the VESALIUS-CV analysis shows that high-risk patients with diabetes without known atherosclerosis experienced a 31% relative reduction in first MACE (HR 0.69), with LDL-C lowered to ~52 mg/dL. The signal is clear: earlier, deeper lipid lowering matters. Yet questions remain—cost, long-term safety, and who benefits most. Are...

A quiet valve, a loud message. 🫀 The 10-year follow-up of the RECOVERY trial in The New England Journal of Medicine shows that early surgery in asymptomatic very severe aortic stenosis is not premature—it is protective. A striking reduction in cardiovascular mortality (HR 0.10, P=0.002) and sustained divergence of Kaplan–Meier curves challenge the long-held "watchful waiting" paradigm. Perhaps we...

Cardiology stands at a quiet inflection point. We have spent decades treating plaque—yet the real opportunity lies upstream: preventing atheroma before it begins. Emerging evidence reminds us that cumulative LDL exposure, not just snapshots of risk, shapes lifelong cardiovascular destiny.   A shift is underway: → From 10-year risk to lifetime risk → From reactive care to proactive prevention → Fro...

Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine. Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect.   This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivota...

Sound. Mask. Mastery 🎼   A fascinating insight from C. V. Raman reminds us that hearing is not just perception—it is physics in motion. His 1926 Nature note reveals how lower tones quietly veil higher ones, shaping what we think we hear.   In music—and in science—what is hidden often matters most.   #Acoustics #CVRaman #Psychoacoustics #SoundScience #NatureJournal

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨   What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity.   "Neti, Neti" (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman.   In dialogues with Maitreyi and Gargi, he models fearless inquiry, i...

Emerging insights from Nature Spotlight on Nutrition sharpen a simple truth: what we eat matters—but when and how may matter just as much. Morning coffee aligns with lower cardiovascular mortality, plant-forward diets sculpt a favorable microbiome, early-life sugar exposure imprints lifelong risk, and not all potatoes are equal—fried forms carry harm, not the humble baked.   Nutrition is no longer...

Dopamine is not just the "pleasure chemical"—it is the brain's teaching signal 🧠✨   New insights (from Nature ) suggest dopamine shapes how we learn, prioritize, and act—not only through reward, but also via attention, action, and even threat detection 🎯🔁   This evolving paradigm has profound implications for ADHD, addiction, and behavioral medicine 🩺   I've summarized the science into a conc...

A striking study in Science Translational Medicine reveals that the blood–brain barrier remains disrupted years after retirement in contact-sport athletes. This persistent leakiness is linked to systemic inflammation, complement activation, and measurable cognitive decline.   Notably, imaging of BBB dysfunction outperformed conventional blood biomarkers—offering a potential path toward early detec...

The thymus—long dismissed as vestigial in adults—re-emerges as a powerful biomarker of health and therapeutic response.   Two Nature (2026) studies demonstrate that AI-derived thymic health independently predicts all-cause mortality, cardiovascular death, and cancer risk, while also forecasting immunotherapy outcomes across tumor types—performing comparably to PD-L1 and tumor mutation burden.   Th...

A quiet shift is underway in metabolic medicine. A recent Nature study shows that continuous data from wearables—heart rate, sleep, activity—combined with routine labs can detect insulin resistance years before traditional tests. Not snapshots, but a "movie" of physiology.     This opens a wider window for prevention: simpler interventions, earlier action, better outcomes. The future may lie not i...